Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 286

The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.

Gynecologic cancers in pregnancy: guidelines based on a third international consensus meeting

Open access
Amant, F., Berveiller, P., Boere, I.A., Cardonick, E., Fruscio, R., Fumagalli, M., Halaska, M.J., Hasenburg, A., Johansson, A.L.V., Lambertini, M., Lok, C.A.R., Maggen, C., Morice, P., Peccatori, F., Poortmans, P., Van Calsteren, K., Vandenbroucke, T., van Gerwen, M., van den Heuvel-Eibrink, M., Zagouri, F., Zapardiel, I.·2019·Annals of Oncology

Abstract

We aimed to provide comprehensive protocols and promote effective management of pregnant women with gynecological cancers. New insights and more experience have been gained since the previous guidelines were published in 2014. Members of the International Network on Cancer, Infertility and Pregnancy (INCIP), in collaboration with other international experts, reviewed existing literature on their respective areas of expertise. Summaries were subsequently merged into a manuscript that served as a basis for discussion during the consensus meeting. Treatment of gynecological cancers during pregnancy is attainable if management is achieved by collaboration of a multidisciplinary team of health care providers. This allows further optimization of maternal treatment, while considering fetal development and providing psychological support and long-term follow-up of the infants. Nonionizing imaging procedures are preferred diagnostic procedures, but limited ionizing imaging methods can be allowed if indispensable for treatment plans. In contrast to other cancers, standard surgery for gynecological cancers often needs to be adapted according to cancer type and gestational age. Most standard regimens of chemotherapy can be administered after 14 weeks gestational age but are not recommended beyond 35 weeks. C-section is recommended for most cervical and vulvar cancers, whereas vaginal delivery is allowed in most ovarian cancers. Breast-feeding should be avoided with ongoing chemotherapeutic, endocrine or targeted treatment. More studies that focus on the long-term toxic effects of gynecologic cancer treatments are needed to provide a full understanding of their fetal impact. In particular, data on targeted therapies that are becoming standard of care in certain gynecological malignancies is still limited. Furthermore, more studies aimed at the definition of the exact prognosis of patients after antenatal cancer treatment are warranted. Participation in existing registries (www.cancerinpregnancy.org) and the creation of national tumor boards with multidisciplinary teams of care providers (supplementary Box S1, available at Annals of Oncology online) is encouraged.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/annonc/mdz228

Cites

53 of 53 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 53 references

Cited by

See all 286

Metadata

Authors
Amant, F., Berveiller, P., Boere, I. A., Cardonick, E., Fruscio, R., Fumagalli, M., Halaska, M. J., Hasenburg, A., Johansson, A. L. V., Lambertini, M., Lok, C. A. R., Maggen, C., Morice, P., Peccatori, F., Poortmans, P., Van Calsteren, K., Vandenbroucke, T., van Gerwen, M., van den Heuvel-Eibrink, M., Zagouri, F., & Zapardiel, I.
Venue
Annals of Oncology
Publisher
Elsevier BV
Published
2019-10
Volume
30
Issue
10
Pages
1601-1612
ISSN
0923-7534 (ISSN-L)
OpenAlex
W2969259138
Cited by
286
References
53
FWCI
24.98
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Gynecologic cancers in pregnancy: guidelines based on a third international consensus meeting. https://app.cochat.ai/papers/10.1093/annonc/mdz228
The paper
Amant, F., Berveiller, P., Boere, I. A., Cardonick, E., Fruscio, R., Fumagalli, M., Halaska, M. J., Hasenburg, A., Johansson, A. L. V., Lambertini, M., Lok, C. A. R., Maggen, C., Morice, P., Peccatori, F., Poortmans, P., Van Calsteren, K., Vandenbroucke, T., van Gerwen, M., van den Heuvel-Eibrink, M., . . . Zapardiel, I. (2019). Gynecologic cancers in pregnancy: guidelines based on a third international consensus meeting. Annals of Oncology. https://doi.org/10.1093/annonc/mdz228

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.